CRISPR Therapeutics AG

The current price of CRSP is 56.13 USD — it has increased by 1.03% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CRISPR Therapeutics AG stocks are traded under the ticker CRSP.

CRISPR Therapeutics AG is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.

CRSP stock is 3.51% volatile and has beta coefficient of 2.53. Check out the list of the most volatile stocks — is CRISPR Therapeutics AG there?

One year price forecast for CRISPR Therapeutics AG has a max estimate of 199.00 USD and a min estimate of 30.00 USD.

CRSP earnings for the last quarter are −1.41 USD whereas the estimation was −1.99 USD which accounts for 29.12% surprise. Estimated earnings for the next quarter are 0.07 USD. See more details about CRISPR Therapeutics AG earnings.

CRISPR Therapeutics AG revenue for the last quarter amounts to 0 USD despite the estimated figure of ‪11.89 M‬ USD. In the next quarter revenue is expected to reach ‪140.94 M‬ USD.

Yes, you can track CRISPR Therapeutics AG financials in yearly and quarterly reports right on TradingView.

CRSP net income for the last quarter is ‪89.35 M‬ USD, while the quarter before that showed ‪−112.15 M‬ USD of net income which accounts for 179.67% change. Track more CRISPR Therapeutics AG financial stats to get the full picture.

Today CRISPR Therapeutics AG has the market capitalization of ‪4.72 B‬, it has decreased by 1.45% over the last week.

No, CRSP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, CRSP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CRISPR Therapeutics AG stock right from TradingView charts — choose your broker and connect to your account.

CRSP reached its all-time high on Jan 15, 2021 with the price of 220.20 USD, and its all-time low was 11.63 USD and was reached on Feb 15, 2017.
See other stocks reaching their highest and lowest prices.

As of Apr 18, 2024, the company has 407.00 employees. See our rating of the largest employees — is CRISPR Therapeutics AG on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CRISPR Therapeutics AG technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CRISPR Therapeutics AG stock shows the sell signal. See more of CRISPR Therapeutics AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on CRISPR Therapeutics AG future price: according to them, CRSP price has a max estimate of 199.00 USD and a min estimate of 30.00 USD. Read a more detailed CRISPR Therapeutics AG forecast: see what analysts think of CRISPR Therapeutics AG and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CRISPR Therapeutics AG EBITDA is ‪−179.28 M‬ USD, and current EBITDA margin is −54.61%. See more stats in CRISPR Therapeutics AG financial statements.